$DMTKQ
DermTech Inc

2020 Q4 Form 10-Q Financial Statement

#000156459020053008 Filed on November 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q4
Revenue $2.120M $1.362M $1.590M
YoY Change 33.33% 141.06%
Cost Of Revenue $1.730M $1.608M $1.200M
YoY Change 44.17% 106.42%
Gross Profit $400.0K -$246.0K $390.0K
YoY Change 2.56% 14.95%
Gross Profit Margin 18.87% -18.06% 24.53%
Selling, General & Admin $7.950M $7.533M $4.850M
YoY Change 63.92% 45.2%
% of Gross Profit 1987.5% 1243.59%
Research & Development $1.910M $1.618M $650.0K
YoY Change 193.85% 113.74%
% of Gross Profit 477.5% 166.67%
Depreciation & Amortization $180.0K $200.0K $30.00K
YoY Change 500.0% 900.0%
% of Gross Profit 45.0% 7.69%
Operating Expenses $9.860M $9.151M $5.500M
YoY Change 79.27% 53.93% 1560.15%
Operating Profit -$9.460M -$9.397M -$5.110M
YoY Change 85.13% 52.57% 1442.43%
Interest Expense $20.00K $9.000K $0.00
YoY Change -102.47% -100.0%
% of Operating Profit
Other Income/Expense, Net -$1.260M $116.0K $0.00
YoY Change -73.21%
Pretax Income -$9.440M -$9.390M -$5.120M
YoY Change 84.38% 63.87% -1124.0%
Income Tax
% Of Pretax Income
Net Earnings -$9.440M -$9.281M -$5.120M
YoY Change 84.38% 62.09% -1116.75%
Net Earnings / Revenue -445.28% -681.42% -322.01%
Basic Earnings Per Share
Diluted Earnings Per Share -$478.9K -$496.0K -$426.0K
COMMON SHARES
Basic Shares Outstanding 19.60M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $63.80M $51.50M $15.40M
YoY Change 314.29% 140.65%
Cash & Equivalents $24.25M $14.63M $15.37M
Short-Term Investments $39.50M $36.90M
Other Short-Term Assets $79.00K $1.900M $25.00K
YoY Change 216.0% 7816.67% 400.0%
Inventory $104.0K $115.0K $35.00K
Prepaid Expenses
Receivables $1.480M $1.007M $680.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $66.88M $54.53M $17.15M
YoY Change 289.98% 130.16% 217.65%
LONG-TERM ASSETS
Property, Plant & Equipment $2.731M $2.324M $977.0K
YoY Change 179.53% 1006.67% 354.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $167.0K $167.0K $84.00K
YoY Change 98.81% 98.81%
Total Long-Term Assets $2.898M $2.491M $1.061M
YoY Change 173.14% 747.28% -99.26%
TOTAL ASSETS
Total Short-Term Assets $66.88M $54.53M $17.15M
Total Long-Term Assets $2.898M $2.491M $1.061M
Total Assets $69.78M $57.03M $18.21M
YoY Change 283.18% 137.72% -87.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.573M $819.0K $1.609M
YoY Change -2.24% -18.43% 129.86%
Accrued Expenses $763.0K $484.0K $218.0K
YoY Change 250.0% 183.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K
YoY Change
Total Short-Term Liabilities $5.425M $4.098M $5.722M
YoY Change -5.19% -19.65% 664.16%
LONG-TERM LIABILITIES
Long-Term Debt $200.0K $0.00 $0.00
YoY Change
Other Long-Term Liabilities $600.0K $700.0K
YoY Change
Total Long-Term Liabilities $800.0K $700.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.425M $4.098M $5.722M
Total Long-Term Liabilities $800.0K $700.0K $0.00
Total Liabilities $7.940M $5.374M $6.350M
YoY Change 25.04% 5.37% -42.37%
SHAREHOLDERS EQUITY
Retained Earnings -$128.0M -$117.3M -$91.55M
YoY Change 39.84% 36.43% 28.27%
Common Stock $189.9M $169.0M $103.4M
YoY Change 83.6% 3134.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $61.84M $51.65M $11.86M
YoY Change
Total Liabilities & Shareholders Equity $69.78M $57.03M $18.21M
YoY Change 283.18% 137.72% 221.52%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q4
OPERATING ACTIVITIES
Net Income -$9.440M -$9.281M -$5.120M
YoY Change 84.38% 62.09% -1116.75%
Depreciation, Depletion And Amortization $180.0K $200.0K $30.00K
YoY Change 500.0% 900.0%
Cash From Operating Activities -$6.740M -$8.160M -$6.080M
YoY Change 10.86% -30.14% 2795.24%
INVESTING ACTIVITIES
Capital Expenditures -$250.0K -$380.0K -$160.0K
YoY Change 56.25% 660.0%
Acquisitions
YoY Change
Other Investing Activities -$2.600M -$36.91M
YoY Change
Cash From Investing Activities -$2.860M -$37.28M -$160.0K
YoY Change 1687.5% 74460.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 19.23M -1.040M 170.0K
YoY Change 11211.76% -103.66% 466.67%
NET CHANGE
Cash From Operating Activities -6.740M -8.160M -6.080M
Cash From Investing Activities -2.860M -37.28M -160.0K
Cash From Financing Activities 19.23M -1.040M 170.0K
Net Change In Cash 9.630M -46.48M -6.070M
YoY Change -258.65% -378.16% 3272.22%
FREE CASH FLOW
Cash From Operating Activities -$6.740M -$8.160M -$6.080M
Capital Expenditures -$250.0K -$380.0K -$160.0K
Free Cash Flow -$6.490M -$7.780M -$5.920M
YoY Change 9.63% -33.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5722000
CY2019Q4 us-gaap Liabilities
Liabilities
5722000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15374000
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
84000
CY2019Q4 us-gaap Assets
Assets
18211000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1609000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1142000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4098000
CY2020Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
679000
CY2020Q3 us-gaap Liabilities
Liabilities
4777000
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
565000
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
1608000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10973000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
757000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3380000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2939000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3212000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10980000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6446000
us-gaap Operating Expenses
OperatingExpenses
25333000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9397000
dei Entity Address City Or Town
EntityAddressCityOrTown
La Jolla
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
484000
CY2020Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1005000
CY2019Q4 dmtk Deferred Underwriting Fees Current
DeferredUnderwritingFeesCurrent
1363000
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
103599000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-91111000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
12489000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18211000
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-2870849
dei Local Phone Number
LocalPhoneNumber
450-4222
CY2019Q4 us-gaap Inventory Net
InventoryNet
35000
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
977000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92037
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1061000
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1881000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
54534000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
17150000
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
36906000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2324000
dei Entity Address Address Line1
EntityAddressAddressLine1
11099 N. Torrey Pines Road
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14625000
dei City Area Code
CityAreaCode
858
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
680000
CY2020Q3 us-gaap Inventory Net
InventoryNet
115000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19590998
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12344818
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19590998
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12344818
us-gaap Depreciation
Depreciation
58000
us-gaap Cost Of Revenue
CostOfRevenue
2100000
CY2019Q3 us-gaap Gross Profit
GrossProfit
-214000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3764000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1775000
us-gaap Gross Profit
GrossProfit
-492000
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4594000
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1976000
dei Trading Symbol
TradingSymbol
DMTK
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1007000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
167000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
52248000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57025000
CY2020Q3 us-gaap Assets
Assets
57025000
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19595306
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
819000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1790000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
169163000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-116917000
us-gaap Cost Of Revenue
CostOfRevenue
4256000
CY2020Q3 us-gaap Gross Profit
GrossProfit
-246000
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
779000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1618000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
218000
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1390000
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
928000
us-gaap Net Income Loss
NetIncomeLoss
-25806000
us-gaap Net Income Loss
NetIncomeLoss
-14574000
us-gaap Operating Income Loss
OperatingIncomeLoss
-12490000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
258000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
9151000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
5945000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
235000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4000
us-gaap Gross Profit
GrossProfit
-325000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3872000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1847000
us-gaap Operating Expenses
OperatingExpenses
12165000
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-364000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
19000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2084000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5331876
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.73
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1362000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6159000
us-gaap Operating Income Loss
OperatingIncomeLoss
-25825000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
928000
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
9000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2657000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-131000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-355000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
433000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9388000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-5726000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18928418
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7134642
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16069989
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.50
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.80
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.61
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9388000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5726000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25806000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14574000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-5355000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
258000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-5156000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
41000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-3692000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-13691000
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
718000
CY2019Q3 dmtk Adjustments To Additional Paid In Capital Assumed In Business Combination
AdjustmentsToAdditionalPaidInCapitalAssumedInBusinessCombination
420000
CY2019Q3 dmtk Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Convertible Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfConvertiblePreferredStock
4000000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
684000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
18894000
CY2019Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
6.50
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
200000
CY2020Q1 dmtk Adjustments To Additional Paid In Capital Issuance Of Series B1 Convertible Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesB1ConvertiblePreferredStock
30971000
CY2020Q1 dmtk Adjustments To Additional Paid In Capital Issuance Of Series B2 Convertible Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesB2ConvertiblePreferredStock
5071000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
253000
CY2020Q1 dmtk Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
11000
CY2020Q1 dmtk Adjustments To Additional Paid In Capital Issuance Cost Related To Registration
AdjustmentsToAdditionalPaidInCapitalIssuanceCostRelatedToRegistration
-77000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1022000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7001000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
66630000
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000
CY2020Q2 dmtk Stock Issued During Period Value Stock Options Exercised And Rsu Release
StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
123000
CY2020Q2 dmtk Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
471000
CY2020Q2 dmtk Adjustments To Additional Paid In Capital Issuance Cost Related To Registration
AdjustmentsToAdditionalPaidInCapitalIssuanceCostRelatedToRegistration
-5000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1125000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-9417000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
58928000
CY2020Q3 dmtk Stock Issued During Period Value Stock Options Exercised And Rsu Release
StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
24000
CY2020Q3 dmtk Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
300000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1983000
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
355000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1373000
us-gaap Profit Loss
ProfitLoss
-25806000
us-gaap Profit Loss
ProfitLoss
-14574000
us-gaap Depreciation
Depreciation
306000
us-gaap Share Based Compensation
ShareBasedCompensation
3520000
us-gaap Share Based Compensation
ShareBasedCompensation
1200000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
327000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
80000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
903000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1407000
dmtk Increase Decrease In Accounts Payable And Accrued Compensation
IncreaseDecreaseInAccountsPayableAndAccruedCompensation
-218000
dmtk Increase Decrease In Accounts Payable And Accrued Compensation
IncreaseDecreaseInAccountsPayableAndAccruedCompensation
1330000
dmtk Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
1571000
dmtk Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
511000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21937000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11711000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
36906000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1577000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
53000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38483000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-53000
dmtk Payment For Deferred Underwriting Fees
PaymentForDeferredUnderwritingFees
1363000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
77000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
782000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
401000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
759000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
19803000
dmtk Proceeds Received From Close Of Business Combination
ProceedsReceivedFromCloseOfBusinessCombination
1802000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
4000000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2600000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-516000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59671000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28448000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-749000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16684000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15374000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4753000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14625000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21437000
dmtk Issuance Of Common Stock In Litigation Settlement
IssuanceOfCommonStockInLitigationSettlement
1011000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
76000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
10000
dmtk Debt Discount And Derivative Liability At Issuance Of Convertible Notes Payable
DebtDiscountAndDerivativeLiabilityAtIssuanceOfConvertibleNotesPayable
270000
us-gaap Use Of Estimates
UseOfEstimates
<div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(c)</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:normal;"></font>Use of Estimates </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.54%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with U.S.&#160;GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the amounts of revenues and expenses reported during the period. On an ongoing basis, management evaluates these estimates and judgments, including those related to assay revenue, stock-based compensation, short-term marketable securities, accounts receivable, accrued bonus and the realization of deferred tax assets. Actual results may differ from those estimates. </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(g)</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:normal;"></font>Concentration of Credit Risk </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.54%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. As of September 30, 2020, the Company maintained $11.5&#160;million in a sweep account, which maintains cash balances throughout various interest bearing bank accounts under the $250,000 insurance limit provided by the Federal Deposit Insurance Corporation for one federally insured financial institution. The Company has not experienced any losses in such accounts. </p>
CY2019Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.5
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one-for-two
CY2020Q3 us-gaap Depreciation
Depreciation
200000
CY2019Q3 us-gaap Depreciation
Depreciation
20000
CY2020Q3 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
32000
CY2019Q3 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
CY2020Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2020Q3 dmtk Accrued Bonus And Deferred Compensation Current
AccruedBonusAndDeferredCompensationCurrent
1244000
CY2019Q4 dmtk Accrued Bonus And Deferred Compensation Current
AccruedBonusAndDeferredCompensationCurrent
465000
CY2020Q3 dmtk Accrued Severance Current
AccruedSeveranceCurrent
1000
CY2019Q4 dmtk Accrued Severance Current
AccruedSeveranceCurrent
368000
CY2020Q3 dmtk Accrued Consulting Services Current
AccruedConsultingServicesCurrent
39000
CY2019Q4 dmtk Accrued Consulting Services Current
AccruedConsultingServicesCurrent
37000
CY2019Q4 dmtk Accrued Printing Fees Current
AccruedPrintingFeesCurrent
55000
CY2020Q3 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
44000
CY2020Q3 us-gaap Deferred Rent Credit
DeferredRentCredit
292000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1362000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
565000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2019Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2020Q3 us-gaap Security Deposit
SecurityDeposit
11500000
CY2020Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
dmtk Number Of Revenue Streams
NumberOfRevenueStreams
2
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3764000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1775000
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0036
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0168
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0036
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0168
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0169
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0250
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7141
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7350
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.6403
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7320
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7141
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7350
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y7D
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1400000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3500000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1200000
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
13600000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y11M15D
CY2019Q4 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
0
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
36761000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5000
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
36761000
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0
CY2020Q3 us-gaap Prepaid Insurance
PrepaidInsurance
1592000
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
951000
CY2020Q3 dmtk Prepaid Trade Shows Current
PrepaidTradeShowsCurrent
24000
CY2019Q4 dmtk Prepaid Trade Shows Current
PrepaidTradeShowsCurrent
85000
CY2020Q3 dmtk Prepaid Software Development Fees
PrepaidSoftwareDevelopmentFees
214000
CY2020Q3 dmtk Prepaid Subscription Fees
PrepaidSubscriptionFees
51000
CY2019Q4 dmtk Prepaid Subscription Fees
PrepaidSubscriptionFees
21000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4000
CY2020Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2021000
CY2019Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1135000
CY2020Q3 dmtk Computer Equipment Gross
ComputerEquipmentGross
38000
CY2019Q4 dmtk Computer Equipment Gross
ComputerEquipmentGross
15000
CY2020Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
109000
CY2019Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
34000
CY2020Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
678000
CY2019Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
32000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2846000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1216000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
522000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
239000
CY2020Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
545000
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
309000
CY2019Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
88000
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
109000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
38000
CY2019Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
2267042
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
900000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
dmtk Business Combination Number Of Shares Issued For Each Share Of Common Stock
BusinessCombinationNumberOfSharesIssuedForEachShareOfCommonStock
1.16
us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.5
CY2017 dmtk Common Stock Warrants Issued
CommonStockWarrantsIssued
102740
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
400000
CY2020Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
7612
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4787
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
In January 2013, DermTech Operations entered into a non-cancelable lease agreement for its operating facilities. In January 2014, DermTech Operations signed an amendment to the lease to extend the term through January 2017. In November 2016, DermTech Operations signed a second amendment to the lease to extend the term through March 2022. In August 2019, DermTech Operations signed a third amendment to the lease to add additional space, and in September 2019, the Company signed a fourth amendment to the lease to add additional space. In February 2020, the Company signed a fifth amendment to the lease to add additional space. In connection with the Business Combination, the Company assumed all obligations under the lease, as amended, from DermTech Operations.
CY2020Q3 dmtk Tenant Improvement Allowance
TenantImprovementAllowance
300000
CY2020Q3 dmtk Real Estate Rent And Common Area Maintenance Expense
RealEstateRentAndCommonAreaMaintenanceExpense
500000
CY2019Q3 dmtk Real Estate Rent And Common Area Maintenance Expense
RealEstateRentAndCommonAreaMaintenanceExpense
200000
dmtk Real Estate Rent And Common Area Maintenance Expense
RealEstateRentAndCommonAreaMaintenanceExpense
1300000
dmtk Real Estate Rent And Common Area Maintenance Expense
RealEstateRentAndCommonAreaMaintenanceExpense
500000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
336000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1370000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1411000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
478000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3595000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0

Files In Submission

Name View Source Status
0001564590-20-053008-index-headers.html Edgar Link pending
0001564590-20-053008-index.html Edgar Link pending
0001564590-20-053008.txt Edgar Link pending
0001564590-20-053008-xbrl.zip Edgar Link pending
dmtk-10q_20200930.htm Edgar Link pending
dmtk-20200930.xml Edgar Link completed
dmtk-20200930.xsd Edgar Link pending
dmtk-20200930_cal.xml Edgar Link unprocessable
dmtk-20200930_def.xml Edgar Link unprocessable
dmtk-20200930_lab.xml Edgar Link unprocessable
dmtk-20200930_pre.xml Edgar Link unprocessable
dmtk-ex311_9.htm Edgar Link pending
dmtk-ex312_10.htm Edgar Link pending
dmtk-ex31_197.htm Edgar Link pending
dmtk-ex321_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending